Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Antithrombin Supplementation in High-Risk Cardiac Surgery
NCT02037555Phase 2Completed
- Sponsor
- Grifols
- Start
- Jun 2014
- Primary completion
- Jan 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of antithrombin III in Antithrombin deficiency (ATD), sponsored by Grifols. Started Jun 2014; status: completed.
02
Drugs
antithrombin III
03
Conditions
Antithrombin deficiency (ATD)
Beyond the preview
Go deeper on NCT02037555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02037555.